Coya Therapeutics, Inc Common Stock

Price & Volume

Stats

52W Range	$4.75-$10.68
Market Cap	$107M
Shares Short	253,003

Financials

Revenue (12 Mos)	$9.5M
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	-$1.9M
Diluted EPS	-$0.65

News

Yahoo Finance • last year

Coya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter into an Exclusive Collaboration for Development and Commercialization of COYA 302, an Investigational Combination Therapy for Treatment of Amyotrophic Lateral Sclerosis (ALS)

About

CEO	Dr. Arun Swaminathan Ph.D.
CFO	Mr. David S. Snyder
Address	5850 San Felipe Street, Houston, TX, United States, 77057
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	8